Industry News
- Alkermes to push opioid dependence treatment for FDA approval
- Putney pulls in $6.7M, plans growth
- Biotech, pharma foresee higher costs from House health reform bill
- Altus files for Ch. 7 bankruptcy
- Ironwood to net $75M from licensing deal in Japan
- Concert Pharmaceuticals to land $12M from HIV drug's clinical study
- Gloucester Pharmaceuticals’ lymphoma drug wins FDA OK
- Beerman takes CEO post at RXi Pharmaceuticals
- Shire's Gaucher drug gets FDA priority review
- Pro-Pharmaceuticals grabs another piece of $6M funding round
- Synta sees profit gain on broken GSK deal
- Alnara appoints chief medical officer Brettman
- Javelin Pharma attracts $3.9M stock offer
- Virdante Pharmaceuticals boosts first round to $47M
- Vertex Pharma sees wider Q3 loss
- Cephalon pays $30M for option to buy BioAssets
- Synta's failed drug target may be reborn from biomarker discovery
- Sepracor buyout completed; CEO Adams to receive up to $11M
Monday, November 16, 2009
Friday, November 13, 2009
Thursday, November 12, 2009
Tuesday, November 10, 2009
Monday, November 9, 2009
Friday, November 6, 2009
Thursday, November 5, 2009
Wednesday, November 4, 2009
Tuesday, November 3, 2009
Friday, October 30, 2009
Thursday, October 29, 2009
Wednesday, October 28, 2009
Monday, October 26, 2009
Friday, October 23, 2009
Wednesday, October 21, 2009
RSS Feeds
